Tags

Type your tag names separated by a space and hit enter

Effectiveness of neuraminidase inhibitors for severe influenza.
Lancet Respir Med. 2014 May; 2(5):346-8.LR

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Fry AM
Influenza Division, National Centers for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. Electronic address: afry@cdc.gov.

MeSH

Antiviral AgentsEnzyme InhibitorsFemaleHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanMaleNeuraminidaseOseltamivirPandemicsZanamivir

Pub Type(s)

Journal Article
Comment

Language

eng

PubMed ID

24815800

Citation

Fry, Alicia M.. "Effectiveness of Neuraminidase Inhibitors for Severe Influenza." The Lancet. Respiratory Medicine, vol. 2, no. 5, 2014, pp. 346-8.
Fry AM. Effectiveness of neuraminidase inhibitors for severe influenza. Lancet Respir Med. 2014;2(5):346-8.
Fry, A. M. (2014). Effectiveness of neuraminidase inhibitors for severe influenza. The Lancet. Respiratory Medicine, 2(5), 346-8. https://doi.org/10.1016/S2213-2600(14)70068-2
Fry AM. Effectiveness of Neuraminidase Inhibitors for Severe Influenza. Lancet Respir Med. 2014;2(5):346-8. PubMed PMID: 24815800.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effectiveness of neuraminidase inhibitors for severe influenza. A1 - Fry,Alicia M, Y1 - 2014/03/19/ PY - 2014/5/13/entrez PY - 2014/5/13/pubmed PY - 2015/1/6/medline SP - 346 EP - 8 JF - The Lancet. Respiratory medicine JO - Lancet Respir Med VL - 2 IS - 5 SN - 2213-2619 UR - https://www.unboundmedicine.com/medline/citation/24815800/Effectiveness_of_neuraminidase_inhibitors_for_severe_influenza_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S2213-2600(14)70068-2 DB - PRIME DP - Unbound Medicine ER -